BID WM Digital Intervention in Aging
Launched by UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · Apr 1, 2025
Trial Information
Current as of September 10, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called BID WM Digital Intervention in Aging, is looking to see if using a digital program can help improve brain function in older adults. Specifically, the researchers want to find out if this program can enhance working memory (the ability to hold and manipulate information) and inhibitory control (the ability to control impulses). Participants will engage with one of two different digital interventions over a period of up to 8 weeks and will complete a series of cognitive tests and surveys before, immediately after, and six months after the program to see if there are any improvements.
To participate, individuals should be between 12 and 100 years old, have at least 12 years of education, and be fluent in English. They should also have normal vision (or corrected vision) and be medically healthy, including those who might have mild cognitive issues but do not have dementia. However, people under 60, those with certain neurological or psychiatric conditions, or those who have been diagnosed with dementia are not eligible. This trial is not yet recruiting participants, but it offers a chance for eligible older adults to potentially benefit their cognitive health while contributing to important research.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Minimum of 12 years of education
- • English fluency
- • Normal or corrected-to-normal vision
- • Normal or corrected-to-normal vision
- • Medically healthy older adults including those with below-average cognitive performance or mild cognitive impairment patients without dementia
- Exclusion Criteria:
- • Under the age of 60
- • Clinical diagnosis of neurological or psychiatric disorder
- • Visually or hearing impaired without correction to normal
- • Clinical diagnosis of dementia or AD8 score of \>3
- • Regularly (one or more times per week) practicing an instrument within the last year
- • 10 or more years of formal musical instrument training
About University Of California, San Francisco
The University of California, San Francisco (UCSF) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a focus on translating scientific discoveries into effective therapies, UCSF collaborates with a diverse array of stakeholders, including healthcare professionals, industry partners, and patient communities. The university's research programs emphasize interdisciplinary approaches and leverage cutting-edge technology to address complex medical challenges. As a sponsor of clinical trials, UCSF is dedicated to maintaining the highest standards of ethical conduct and scientific rigor, ensuring the safety and well-being of participants while contributing to the broader medical knowledge base.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Francisco, California, United States
Patients applied
Trial Officials
Theodore Zanto, PhD
Principal Investigator
University of California, San Francisco
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported